Robert Huizinga
Vermögen: 67 436 $ am 31.05.2026
Vermögen: 67 436 $ am 31.05.2026
Robert B. Huizinga is the founder of Renalpro.
Dr. Huizinga is Chief Executive Officer & Director at Kane Biotech, Inc. starting in 2025.
Dr. Huizinga is a Member of Sigma Theta Tau International Honor Society of Nursing, Inc. Dr. Huizinga is Principal at Reformation Consulting Services, Inc. Dr. Huizinga was Independent Director at Innovotech, Inc. from 2013 to 2016.
Dr. Huizinga was Director at Biovialife, Inc. Dr. Huizinga was Vice President-Clinical Affairs at Isotechnika Pharma, Inc. from 2002 to 2013.
Dr. Huizinga was Executive Vice President-Research at Aurinia Pharmaceuticals, Inc. from 2020 to 2022.
Dr. Huizinga earned a doctorate from Regent University.
Dr. Huizinga completed graduate studies at the University of Alberta.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KANE BIOTECH INC. 1.61% | 28.05.2026 | 2’932’000 ( 1.61% ) | 67 436 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KANE BIOTECH INC. | Vorstandsvorsitzender | 02.05.2025 |
Sigma Theta Tau International Honor Society of Nursing, Inc.
Sigma Theta Tau International Honor Society of Nursing, Inc. Hospital/Nursing ManagementHealth Services Operates organization for providing nursing care services | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Biovialife, Inc.
Biovialife, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 16.11.2024 |
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.10.2022 |
| INNOVOTECH INC. | Direktor/Vorstandsmitglied | 08.11.2016 |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 23.10.2013 |
Renalpro | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Regent University
Regent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovotech, Inc.
Innovotech, Inc. Medical/Nursing ServicesHealth Services Develops solutions for medical, agricultural and industrial problems caused by microbial biofilms | Health Services |
Kane Biotech, Inc.
Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
University of Alberta
University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigma Theta Tau International Honor Society of Nursing, Inc.
Sigma Theta Tau International Honor Society of Nursing, Inc. Hospital/Nursing ManagementHealth Services Operates organization for providing nursing care services | Health Services |
Isotechnika Pharma, Inc.
Isotechnika Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Biovialife, Inc.
Biovialife, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Renalpro |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen